Active Ingredient History

NOW
  • Now
Eritoran is an investigational drug for the treatment of severe sepsis, an excessive inflammatory response to an infection.   Wikipedia

  • SMILES: CCCCCCCCCCCC(=O)CC(=O)N[C@H]1[C@@H](OP(=O)(O)O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(=O)(O)O)[C@H](OCC[C@@H](CCCCCCC)OC)[C@H]2NC(=O)CCCCCCCCC\C=C/CCCCCC)[C@@H](O)[C@@H]1OCCCCCCCCCC
  • InChIKey: BPSMYQFMCXXNPC-MFCPCZTFSA-N
  • Mol. Mass: 1313.68
  • ALogP: Missing data
  • ChEMBL Molecules:
More Chemistry
3-o-decyl-2-deoxy-6-o-(2-deoxy-3-o-(3-methoxydecyl)-6-o-methyl-2-((1-oxo-11-octadecenyl)amino)-4-o-phosphonoglucopyranosyl)-2-((1,3-dioxotetradecyl)amino)-1-(dihydroxy phosphate)glucopyranose | b1287 | b 1287 | b1287 saccharide | e5564 | eritoran | eritoran sodium | eritoran tetrasodium

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue